CFTR and cystic fibrosis: Recently, as the studies in this report were being written for publication, two groups independently reported that co-administration of VX-770 with VX-809 for 48 hours decreased the ability of VX-809 to increase F508del-CFTR Cl currents in primary cultures of CF-HBE cells [22,23].